219 related articles for article (PubMed ID: 36401326)
1. Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol.
Haddad LB; Herring GB; Mehta CC; Staple T; Young MR; Govindaraj S; Velu V; Smith AK
BMC Womens Health; 2022 Nov; 22(1):456. PubMed ID: 36401326
[TBL] [Abstract][Full Text] [Related]
2. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
3. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
[TBL] [Abstract][Full Text] [Related]
4. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
5. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
Achilles SL; Meyn LA; Mhlanga FG; Matubu AT; Stoner KA; Beamer MA; Chirenje ZM; Hillier SL
Am J Reprod Immunol; 2020 Sep; 84(3):e13287. PubMed ID: 32533883
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
Kourtis AP; Wiener J; Hurst S; Nelson JAE; Cottrell ML; Corbett A; Chinula L; Msika A; Haddad LB; Tang JH
J Acquir Immune Defic Syndr; 2019 Jun; 81(2):163-165. PubMed ID: 31095006
[TBL] [Abstract][Full Text] [Related]
7. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
Buckner LR; Drobnis EZ; Augustine MS; Rogers LK; Akers J; Mott PD; Hope TJ; Quayle AJ; Schust DJ
PLoS One; 2019; 14(5):e0214152. PubMed ID: 31095572
[TBL] [Abstract][Full Text] [Related]
8. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
[TBL] [Abstract][Full Text] [Related]
9. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.
Kourtis AP; Haddad L; Tang J; Chinula L; Hurst S; Wiener J; Ellington S; Nelson JA; Corbett A; De Paris K; King CC; Hosseinipour M; Hoffman IF; Jamieson DJ
Contemp Clin Trials; 2017 Jan; 52():27-34. PubMed ID: 27836505
[TBL] [Abstract][Full Text] [Related]
11. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
12. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
13. Genital inflammatory status and the innate immune response to contraceptive initiation.
Radzey N; Harryparsad R; Meyer B; Chen PL; Gao X; Morrison C; Taku O; Williamson AL; Mehou-Loko C; Lefebvre d'Hellencourt F; Buck G; Smit J; Strauss J; Nanda K; Ahmed K; Beksinska M; Serrano M; Bailey V; Masson L; Deese J
Am J Reprod Immunol; 2022 Aug; 88(2):e13542. PubMed ID: 35394678
[TBL] [Abstract][Full Text] [Related]
14. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
15. No-daily hormonal contraception today: general overview and application in specific clinical settings.
Bounous VE; Actis S; Rosso R; Giorgi M; Tiranini L; Nappi RE; Biglia N
Gynecol Endocrinol; 2023 May; 39(1):2214626. PubMed ID: 37199597
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Tanko RF; Bunjun R; Dabee S; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Harryparsad R; Happel AU; Gamieldien H; Qumbelo Y; Sinkala M; Scoville CW; Heller K; Baeten JM; Bosinger SE; Burgener A; Heffron R; Jaspan HB; Passmore JAS
J Infect Dis; 2022 Sep; 226(5):907-919. PubMed ID: 35263421
[TBL] [Abstract][Full Text] [Related]
17. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
Hapgood JP; Kaushic C; Hel Z
Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
[TBL] [Abstract][Full Text] [Related]
18. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
19. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
[TBL] [Abstract][Full Text] [Related]
20. Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
Li L; Zhou J; Wang W; Huang L; Tu J; Baiamonte L; Stark M; Mills M; Hope TJ; Drobnis EZ; Quayle AJ; Schust DJ
Reprod Biol Endocrinol; 2019 Feb; 17(1):26. PubMed ID: 30795774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
